# AMT-676 in Patients With Advanced Solid Tumors

> **NCT06400485** · EARLY_PHASE1 · RECRUITING · sponsor: **Multitude Therapeutics Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** AMT-676

## Key facts

- **NCT ID:** NCT06400485
- **Lead sponsor:** Multitude Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-18
- **Primary completion:** 2027-05-15
- **Final completion:** 2027-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400485, "AMT-676 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06400485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*